Recent Advances in Nanotechnology-Based Drug Delivery Systems: Current Trends and Future Perspectives-A Review
Keywords:
Nanotechnology, Drug delivery, Nanoparticles, Lipid nanoparticles, Targeted drug delivery, NanomedicineAbstract
Nanotechnology has emerged as an important approach for overcoming several limitations associated with conventional drug delivery systems. Poor aqueous solubility, low bioavailability, rapid degradation, nonspecific distribution, short circulation time and systemic toxicity can restrict the therapeutic effectiveness of many active pharmaceutical ingredients. Nanotechnology-based drug delivery systems are designed to improve drug solubility, stability, absorption, pharmacokinetics, tissue distribution and therapeutic efficacy while potentially reducing undesirable adverse effects. A wide range of nanosystems has been investigated, including polymeric nanoparticles, lipid nanoparticles, liposomes, nanostructured lipid carriers, solid lipid nanoparticles, nanoemulsions, dendrimers, micelles, nanogels and inorganic nanoparticles. Recent developments have expanded the application of these systems toward targeted drug delivery, controlled release, cancer therapy, gene delivery, vaccine delivery, antimicrobial therapy and personalized medicine. Lipid nanoparticles have gained particular importance because of their successful application in nucleic-acid delivery, including messenger RNA-based therapeutics and vaccines. Advances in surface engineering have enabled nanoparticles to be modified with ligands, antibodies, peptides and other targeting molecules to improve delivery to specific cells or tissues. Stimuli-responsive systems can release therapeutic agents in response to pH, temperature, enzymes, light or other biological conditions. Nanotechnology is also increasingly being combined with artificial intelligence, microfluidics, biomaterials engineering and advanced imaging technologies to improve formulation development and characterization. Despite substantial progress, challenges remain concerning long-term toxicity, biodegradability, manufacturing scalability, reproducibility, physicochemical characterization, stability, regulatory requirements and cost. Successful translation of nanomedicines therefore requires careful consideration of formulation design, pharmacokinetics, toxicology, manufacturing and regulatory quality. This review discusses recent advances in nanotechnology-based drug delivery systems, including major nanocarriers, mechanisms of drug delivery, targeted and stimuli-responsive systems, applications in different therapeutic areas, current challenges and future perspectives.

.